Prolgolimab Monotherapy or in Combination With Bendamustine for r/r Classical Hodgkin Lymphoma
Clinical trial NCT05757466 · UNKNOWN
Trial details
- NCT number
- NCT05757466
- Sponsor
- St. Petersburg State Pavlov Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-19
- Primary completion
- 2024-03-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.